Elisabet Uribe-Carretero

Ms. Elisabet Uribe-Carretero

Universidad de Extremadura, Cáceres, Extremadura, Spain
+2
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
MNMireia Niso-Santano
Mireia Niso-Santano
MRMario Rodríguez-Arribas
Mario Rodríguez-Arribas
RGRubén Gómez-Sánchez
Rubén Gómez-Sánchez
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
Jose Manuel FuentesJose Manuel Fuentes
Jose Manuel Fuentes

9 September 2020 in Aging
Verified
Journal Article
Open access
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
JMJose A. Morales-García
Jose A. Morales-García
MNMireia Niso-Santano
Mireia Niso-Santano
RGRosa A. González-Polo
Rosa A. González-Polo
EUElisabet Uribe-Carretero
Elisabet Uribe-Carretero
Jose Manuel FuentesJose Manuel Fuentes
Jose Manuel Fuentes
The research of new biomarkers for Parkinson’s disease is essential for accurate and precocious diagnosis, as well as for the discovery of new potential disease mechanisms and drug targets. The main objective of this work was to identify metabolic changes that might serve as biomarkers for the diagnosis of this neurodegenerative disorder. For this, we profiled the plasma metabolome from mice with neurotoxin-induced Parkinson’s disease as well as from patients with familial or sporadic Parkinson’s disease. By using mass spectrometry technology, we analyzed the complete metabolome from healthy volunteers compared to patients with idiopathic or familial (carrying the G2019S or R1441G mutations in the LRRK2 gene) Parkinson’s disease, as well as, from mice treated with 6-hydroxydopamine to induce Parkinson disease. Both human and murine Parkinson was accompanied by an increase in plasma levels of unconjugated bile acids (cholic acid, deoxycholic acid and lithocholic acid) and purine base intermediary metabolites, in particular hypoxanthine. The comprehensive metabolomic analysis of plasma from Parkinsonian patients underscores the importance of bile acids and purine metabolism in the pathophysiology of this disease. Therefore, plasma measurements of certain metabolites related to these pathways might contribute to the diagnosis of Parkinson’s Disease.

1 June 2016 in Data in Brief
Verified
Journal Article
Open access
RGRubén Gómez-Sánchez
Rubén Gómez-Sánchez
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
MRMario Rodríguez-Arribas
Mario Rodríguez-Arribas
José Manuel Bravo San PedroJosé Manuel Bravo San Pedro
José Manuel Bravo San Pedro
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
Rosa A. Gonzalez-PoloRosa A. Gonzalez-Polo
Rosa A. Gonzalez-Polo
We characterized the dynamics of autophagy in vitro using four different cell systems and analyzing markers widely used in this field, i.e. LC3 (microtubule-associated protein 1 light chain 3; protein recruited from the cytosol (LC3-I) to the autophagosomal membrane where it is lipidated (LC3-II)) and p62/SQSTM1 (adaptor protein that serves as a link between LC3 and ubiquitinated substrates), (Klionsky et al., 2016) [1]. Data provided include analyses of protein levels of LC3 and p62 by Western-blotting and endogenous immunofluorescence experiments, but also p62 mRNA levels obtained by quantitative PCR (qPCR). To monitor the turnover of these autophagy markers and, thus, measure the flux of this pathway, cells were under starvation conditions and/or treated with bafilomycin A1 (Baf. A1) to block fusion of autophagosomes with lysosomes.

20 March 2022 in Molecular & Cellular Oncology
Verified
Journal Article
Open access
MBMercedes Blanco-Benítez
Mercedes Blanco-Benítez
ACAna Calderón-Fernández
Ana Calderón-Fernández
SCSaray Canales-Cortés
Saray Canales-Cortés
EAEva Alegre-Cortés
Eva Alegre-Cortés
EUElisabet Uribe-Carretero
Elisabet Uribe-Carretero
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
Phenolic compounds derived from olive oil have beneficial health properties against cancer, neurodegenerative, and metabolic diseases. Therefore, there are discrepancies in their impact on mitochondrial function that result in changes in oxidative capacity, mitochondrial respiration, and energetic demands. This review focuses on the versatile role of oleuropein, a potent antioxidant that regulates the AMPK/SIRT1/mTOR pathway to modulate autophagy/mitophagy and maintain metabolic homeostasis.

27 August 2021 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
MPMarta Paredes
Marta Paredes
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
EUElisabet Uribe-Carretero
Elisabet Uribe-Carretero
ABAriadna Bargiela
Ariadna Bargiela
MNMireia Niso-Santano
Mireia Niso-Santano
Autophagy is a conserved intracellular catabolic pathway that removes cytoplasmic components to contribute to neuronal homeostasis. Accumulating evidence has increasingly shown that the induction of autophagy improves neuronal health and extends longevity in several animal models. Therefore, there is a great interest in the identification of effective autophagy enhancers with potential nutraceutical or pharmaceutical properties to ameliorate age-related diseases, such as neurodegenerative disorders, and/or promote longevity. Queen bee acid (QBA, 10-hydroxy-2-decenoic acid) is the major fatty acid component of, and is found exclusively in, royal jelly, which has beneficial properties for human health. It is reported that QBA has antitumor, anti-inflammatory, and antibacterial activities and promotes neurogenesis and neuronal health; however, the mechanism by which QBA exerts these effects has not been fully elucidated. The present study investigated the role of the autophagic process in the protective effect of QBA. We found that QBA is a novel autophagy inducer that triggers autophagy in various neuronal cell lines and mouse and fly models. The beclin-1 (BECN1) and mTOR pathways participate in the regulation of QBA-induced autophagy. Moreover, our results showed that QBA stimulates sirtuin 1 (SIRT1), which promotes autophagy by the deacetylation of critical ATG proteins. Finally, QBA-mediated autophagy promotes neuroprotection in Parkinson’s disease in vitro and in a mouse model and extends the lifespan of Drosophila melanogaster. This study provides detailed evidences showing that autophagy induction plays a critical role in the beneficial health effects of QBA.

15 June 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
ECEva Alegre Cortés
Eva Alegre Cortés
AMAlicia Muriel-González
Alicia Muriel-González
SCSaray Canales-Cortés
Saray Canales-Cortés
EUElisabet Uribe-Carretero
Elisabet Uribe-Carretero
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
Parkinson’s disease (PD) is a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. This neuronal loss, inherent to age, is related to exposure to environmental toxins and/or a genetic predisposition. PD-induced cell death has been studied thoroughly, but its characterization remains elusive. To date, several types of cell death, including apoptosis, autophagy-induced cell death, and necrosis, have been implicated in PD progression. In this study, we evaluated necroptosis, which is a programmed type of necrosis, in primary fibroblasts from PD patients with and without the G2019S leucine-rich repeat kinase 2 (LRRK2) mutation and in rotenone-treated cells (SH-SY5Y and fibroblasts). The results showed that programmed necrosis was not activated in the cells of PD patients, but it was activated in cells exposed to rotenone. Necrostatin-1 (Nec-1), an inhibitor of the necroptosis pathway, prevented rotenone-induced necroptosis in PD models. However, Nec-1 affected mitochondrial morphology and failed to protect mitochondria against rotenone toxicity. Therefore, despite the inhibition of rotenone-mediated necroptosis, PD models were susceptible to the effects of both Nec-1 and rotenone.